Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature
Authors
Keywords
-
Journal
Diagnostics
Volume 11, Issue 2, Pages 199
Publisher
MDPI AG
Online
2021-01-29
DOI
10.3390/diagnostics11020199
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mismatch Repair Deficiency in Ovarian Carcinoma
- (2020) Susanna Leskela et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
- (2020) Laura Martin de la Fuente et al. VIRCHOWS ARCHIV
- PD-L1 Expression and CD8+ Tumor-infiltrating Lymphocytes in Different Types of Tubo-Ovarian Carcinoma and Their Prognostic Value in High-grade Serous Carcinoma
- (2020) Hao Chen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma
- (2020) Roman E. Zyla et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- DNA Mismatch Repair–deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas
- (2020) Sheila E. Segura et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma
- (2020) M. Herman Chui et al. MODERN PATHOLOGY
- Mucinous Ovarian Carcinoma
- (2019) Philippe Morice et al. NEW ENGLAND JOURNAL OF MEDICINE
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach
- (2019) C Luchini et al. ANNALS OF ONCOLOGY
- Ovarian Cancer Immunotherapy: Turning up the Heat
- (2019) Eleonora Ghisoni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2019) Antonio González-Martín et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review
- (2019) Lorena Alves Teixeira et al. JOURNAL OF CLINICAL PATHOLOGY
- The molecular origin and taxonomy of mucinous ovarian carcinoma
- (2019) Dane Cheasley et al. Nature Communications
- Clinicopathologic, Immunohistochemical, and Molecular Characteristics of Ovarian Serous Carcinoma With Mixed Morphologic Features of High-grade and Low-grade Serous Carcinoma
- (2019) Shabnam Zarei et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Endometriosis‐related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions
- (2019) W Glenn McCluggage HISTOPATHOLOGY
- Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances
- (2019) Laura Casey et al. HISTOPATHOLOGY
- Targeted therapies in gynaecological cancers
- (2019) Shanthini M Crusz et al. HISTOPATHOLOGY
- Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract
- (2018) Jelena Mirkovic et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
- (2018) C Cruz et al. ANNALS OF ONCOLOGY
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
- (2018) Cécile Le Page et al. BMC CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BRAF V 600E mutations and immunohistochemical expression of VE1 protein in low-grade serous neoplasms of the ovary
- (2018) Gulisa Turashvili et al. HISTOPATHOLOGY
- Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics
- (2018) Jaime Prat et al. HUMAN PATHOLOGY
- Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study
- (2018) Iñigo Espinosa et al. HUMAN PATHOLOGY
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract
- (2018) Jennifer Pors et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- SWI/SNF Complexes in Ovarian Cancer: Mechanistic Insights and Therapeutic Implications
- (2018) Rugang Zhang et al. MOLECULAR CANCER RESEARCH
- Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
- (2018) Marthe M. de Jonge et al. CLINICAL CANCER RESEARCH
- Nuclear β-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome
- (2018) Linyuan Wang et al. HISTOPATHOLOGY
- Endometrial Carcinoma Diagnosis
- (2018) Robert A. Soslow et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma
- (2018) W. Glenn McCluggage et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer
- (2018) Alicia Latham et al. JOURNAL OF CLINICAL ONCOLOGY
- Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
- (2018) Kathleen Moore et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blinded histopathological characterisation of POLE exonuclease domain- mutant endometrial cancers: sheep in wolf's clothing
- (2017) Inge C Van Gool et al. HISTOPATHOLOGY
- Association of Hormone Receptor Expression with Survival in Ovarian Endometrioid Carcinoma: Biological Validation and Clinical Implications
- (2017) Peter Rambau et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups
- (2017) Carlos Parra-Herran et al. MODERN PATHOLOGY
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type
- (2016) Michelle Moh et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
- (2016) Piera Gargiulo et al. CANCER TREATMENT REVIEWS
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- NovelBRCA1andBRCA2Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
- (2016) Robbert D.A. Weren et al. HUMAN MUTATION
- Prognostic Significance of POLE Exonuclease Domain Mutations in High-Grade Endometrioid Endometrial Cancer on Survival and Recurrence
- (2016) Caroline C. Billingsley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition
- (2016) Siming Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
- (2016) Kyle C. Strickland et al. Oncotarget
- Ovarian Seromucinous Carcinoma
- (2015) Jennifer Taylor et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy
- (2015) Christine S. Walsh GYNECOLOGIC ONCOLOGY
- Clear cell carcinoma of the ovary: evaluation of prognostic parameters based on a clinicopathological analysis of 100 cases
- (2015) Jennifer A Bennett et al. HISTOPATHOLOGY
- Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma
- (2015) Lien N. Hoang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Sustained response to vemurafenib in a low grade serous ovarian cancer with a BRAF V600E mutation
- (2015) Pierre Combe et al. INVESTIGATIONAL NEW DRUGS
- Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
- (2015) Sally M. Hunter et al. Oncotarget
- Association of Polymerase e–Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1
- (2015) Brooke E. Howitt et al. JAMA Oncology
- The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
- (2014) J. L. Meisel et al. ANNALS OF ONCOLOGY
- Functional Ex Vivo Assay to Select Homologous Recombination-Deficient Breast Tumors for PARP Inhibitor Treatment
- (2014) K. A. T. Naipal et al. CLINICAL CANCER RESEARCH
- POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium
- (2014) Bo Meng et al. GYNECOLOGIC ONCOLOGY
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma
- (2014) Dominique Berton-Rigaud et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer
- (2014) David N. Church et al. JNCI-Journal of the National Cancer Institute
- ACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome
- (2014) OBSTETRICS AND GYNECOLOGY
- The target therapy of ovarian clear cell carcinoma
- (2014) Ying Jin et al. OncoTargets and Therapy
- Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes
- (2014) Siân Jones et al. Nature Communications
- Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
- (2014) Filip Janku et al. Cell Reports
- BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management
- (2014) Giulia Girolimetti et al. Biomed Research International
- Identifying Lynch Syndrome in Patients With Ovarian Carcinoma
- (2013) Michael Herman Chui et al. ADVANCES IN ANATOMIC PATHOLOGY
- KRAS(but notBRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
- (2013) Yvonne T Tsang et al. JOURNAL OF PATHOLOGY
- Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
- (2013) Ren-Chin Wu et al. JOURNAL OF PATHOLOGY
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer
- (2013) Tjalling Bosse et al. MODERN PATHOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma
- (2012) Russell Vang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
- (2012) Roel G.W. Verhaak et al. JOURNAL OF CLINICAL INVESTIGATION
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carcinosarcoma of the ovary: A review of the literature
- (2011) Marcela G. del Carmen et al. GYNECOLOGIC ONCOLOGY
- Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma
- (2011) Linda E Kelemen et al. LANCET ONCOLOGY
- Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component
- (2011) Renske A de Jong et al. MODERN PATHOLOGY
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma
- (2011) Sian C. Hicks et al. PATHOLOGY
- PARP Inhibitors in BRCA Gene-Mutated Ovarian Cancer and Beyond
- (2011) Susana Banerjee et al. Current Oncology Reports
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Morphologic Spectrum of Immunohistochemically Characterized Clear Cell Carcinoma of the Ovary
- (2010) Deborah DeLair et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer
- (2010) Bryan T.J. Hennessy et al. JOURNAL OF CLINICAL ONCOLOGY
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- Ovarian Clear Cell Carcinoma With Papillary Features: A Potential Mimic of Serous Tumor of Low Malignant Potential
- (2009) Ankur R. Sangoi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
- (2009) Jessica N McAlpine et al. BMC CANCER
- Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers
- (2009) Patricia A Shaw et al. MODERN PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started